Aspectos Clínicos y Epidemiológicos del VIH y Condiciones Asociadas

Virseda-Berdices, A; Requena, B; Berenguer, J; Gónzalez-Garcia, J; Gonzalez-Riano, C; Diez, C; Hontañón, V; Muñoz-Garcia, P; Fernández-Rodriguez, A; Barbas, C; Resino, S; Martin-Escolano, R; Jimenez-Sousa, MA.

Long-term effects of HCV eradication on lipid profiles associated with MASLD among people with HIV with advanced fibrosis or cirrhosis

Journal of Infection and Public Health. 2025; 18(12): [doi:10.1016/j.jiph.2025.102981]

Vazquez-Alejo, E; Espinar-Buitrago, MD; Magro-Lopez, E; Tarancon-Diez, L; Díez, C; Bernardino, JI; Rull, A; de los Santos, I; Alonso, R; Zamora, A; Jiménez, JL; Muñoz-Fernández, MA.

Deciphering long-term immune effects of HIV-1/SARS-CoV-2 co-infection: a longitudinal study

MEDICAL MICROBIOLOGY AND IMMUNOLOGY. 2025; 214(1): [doi:10.1007/s00430-024-00813-z]

Garrido-Rodriguez, V; Bulnes-Ramos, A; Olivas-Martinez, I; Pozo-Balado, MD; Tejerina-Picado, F; Gutierrez, F; Marco-Sánchez, C; Tiraboschi, JM; Castillo-Navarro, A; Bernal, E; Garcia-Guerrero, MC; Puertas, MC; Peraire, J; Rull, A; Martinez-Picado, J; Pacheco, YM; CoRIS Cohort.

Unveiling altered CD8 T-cell metabolism and homeostatic proliferation behind a low CD4/CD8 ratio in ART-suppressed HIV individuals with normal CD4 recovery

Frontiers in Immunology. 2025; 16: [doi:10.3389/fimmu.2025.1617674]

Berenguer, J; Fanciulli, C; Arcos, MM; Vivancos, MJ; Domingo, P; Hernando, A; Barrado, J; Ryan, P; Navarro, J; Palacios, R; Morano, LE; Iribarren, JA; Martínez, R; Galindo, MJ; de los Santos, I; López-Cruz, I; Rivero, A; Pérez-Latorre, L; Giner, L; Fariñas, MC; García, C; Montero-Alonso, M; Ferrero, OL; Villoslada, A; Soler-González, JF; Sanz, J; Rodríguez, S; Losa, JE; Bernal, E; Veloso, S; Pérez-Martínez, L; Mateos, F; Arbonés, L; Franch, R; Corps, D; Martín, C; Alonso, G; Clavero-Olmos, M; Silvariño, R; Teira, R; Belinchón, O; de Miguel, M; Jarrín, I; González-García, J.

Trends in Hepatitis C Virus Infection Prevalence Among People With HIV in Spain Over 2 Decades (2002-2023)

CLINICAL INFECTIOUS DISEASES. 2025; : [doi:10.1093/cid/ciaf407]

Bernal, E; Martínez-Rodríguez, R; Gómez, JM; Tomás, C; García-Villalba, E; Valero, S; Muñoz, A; Alcaraz, A; Díez, C; García-Fraile, LJ; Gómez-García, T; Navarro-Marcotegui, M; Alemán-Valls, MR; Olalla, J; Masiá, M; Gutiérrez, F.

Low-level viremia linked to virological failure but not clinical events

AIDS. 2025; 39(11): 1545-1557 Nº de citas: 1 [doi:10.1097/QAD.0000000000004248]

Tarazona, ED; Moraga, E; Fons-Contreras, M; Vaquer, R; Sánchez-Palomino, S; Vallejo-Palma, G; Calderón-Vicente, S; Vicens-Artés, S; Aldamiz-Echevarria, T; Sañudo, MC; Moreno, C; Armenteros-Yeguas, I; Tiraboschi, J; Bañuls, SR; Alcamí, J; Serrano-Villar, S; Moreno, S.

Identification of Inflammation Markers as Novel Potential Predictors of the HIV-DNA Reservoir Size

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2025; 26(17): [doi:10.3390/ijms26178430]

Manzano, S; Torres-Macho, J; Deihim-Rahampour, N; Cuevas, G; Perez-Garcia, F; Balsalobre, L; Resino, S; Sanchez-Conde, M; Valencia, J; Ryan, P.

Prevalence and patterns of antiretroviral resistance in HIV-infected Latin American asylum seekers

Scientific Reports. 2025; 15(1): [doi:10.1038/s41598-025-13673-1]

Ryan, P; Valencia, J; Pérez-García, F; Quero-Delgado, M; Cuevas, G; Manzano, S; Estévez, S; Martínez, I; Sepúlveda-Crespo, D; Resino, S.

Prevalence and risk factors of active hepatitis C infection among at-risk migrant populations in Madrid, Spain, 2019 to 2023

Eurosurveillance. 2025; 30(29): [doi:10.2807/1560-7917.ES.2025.30.29.2500150]

Chalouni, M; Van Santen, DK; Berenguer, J; Jarrin, I; Miro, JM; Klein, MB; Young, J; Torgersen, J; Rentsch, CT; Gill, MJ; Epstein, RL; Linas, B; Zangerle, R; Surial, B; Rauch, A; Touloumi, G; Papadopoulos, A; Wittkop, L; Van Der Valk, M; Boyd, A; Monforte, AD; Puoti, M; Logan, RW; Rein, SM; Hernán, MA; Lodi, S.

Time to direct-acting antiviral initiation and liver-related events in people with HIV and hepatitis C virus

AIDS. 2025; 39(8): 1074-1079 [doi:10.1097/QAD.0000000000004161]

Franco-Moreno, A; Ryan, P; Munoz-Rivs, N; Valencia, J; Torres-Macho, J; Bacete-Cebrián, S.

Risk of venous thromboembolism in the transgender population on hormone therapy: A systematic review

MEDICINA CLINICA. 2025; 164(12): Nº de citas: 1 [doi:10.1016/j.medcli.2025.106921]

Young, J; Wang, S; Sacks-Davis, R; Stewart, A; van Santen, DK; van der Valk, M; Doyle, JS; Matthews, G; Berenguer, J; Wittkop, L; Lacombe, K; Rauch, A; Stoové, M; Hellard, M; Klein, MB.

Liver Fibrosis Regression in People Living With HIV After Successful Treatment for Hepatitis C

JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES. 2025; 99(2): 166-174 [doi:10.1097/QAI.0000000000003646]

Sepúlveda-Crespo, D; Sánchez-Merino, V; Amigot-Sánchez, R; Rubio-Pérez, A; Díez, C; Hontañón, V; Berenguer, J; González-García, J; García, F; Martínez, I; Yuste, E; Resino, S.

Persistent Low Anti-HIV Neutralizing Antibody Titers in HIV/HCV Coinfection Despite HCV Cure: A 5-Year Longitudinal Analysis

Vaccines. 2025; 13(5): [doi:10.3390/vaccines13050539]

Grinspoon, SK; Watanabe, M; Ribaudo, HJ; Bloomfield, GS; Fichtenbaum, CJ; Umbleja, T; Chu, SM; Fitch, K; Diggs, MR; Zhao, SP; Looby, SE; Currier, JS; Aberg, JA; Malvestutto, CD; Erlandson, KM; Martinez, E; Asupoto, O; Gupta, SK; de Quiros, JCLB; Nixon, D; Bedimo, R; Lu, MT; Douglas, PS; Zanni, M.

Factors Affecting Risk of Cardiovascular Disease (CVD) Events in a Global CVD Prevention Cohort of People With Human Immunodeficiency Virus (HIV)

CLINICAL INFECTIOUS DISEASES. 2025; : Nº de citas: 2 [doi:10.1093/cid/ciaf210]

Muñoz-Gómez, MJ; Ryan, P; Quero-Delgado, M; Martin-Vicente, M; Cuevas, G; Valencia, J; Jiménez, E; Blanca-López, N; Manzano, S; Lazo, JI; Mas, V; Vázquez, M; Sepúlveda-Crespo, D; Torres-Macho, J; Martínez, I; Resino, S.

Antibody Response Against SARS-CoV-2 Spike Protein in People with HIV After COVID-19 Vaccination

Vaccines. 2025; 13(5): [doi:10.3390/vaccines13050480]

Pérez-Valero, I; Mata, DC; Espejo, AC; Gallo, M; de Morales, AGGR; Fanciulli, C; Martín-Carbonero, L; Isbert, SC; Gutiérrez, CH; Asensi, V; Juarez, AR; Rivero, A.

Real-world Effectiveness and Safety of Bictegravir/Emtricitabine/Tenofovir Alafenamide in Comparison With Other Regimens in People With Human Immunodeficiency Virus Starting Therapy With AIDS-Defining Conditions: Results From the CoRIS Cohort-The ACTUAS II Study

CLINICAL INFECTIOUS DISEASES. 2025; : [doi:10.1093/cid/ciaf162]

Ollero, MJF; Ryan, P; Dolengevich-Segal, H; Cano-Smith, J; Ramos-Ruperto, L; Cabello, A; Sanchez-Conde, M; Cabello, N; Sanz, J; García-Fraile, LJ; Perez-Latorre, L; Bisbal, O; de la Fuente, S; Losa, JE; González-Baeza, A.

Drug Addiction in Gay and Bisexual Men Living with HIV Engaged in Sexualized Drug Use: Recent Drug Use, Polydrug and Depressive Symptoms as Predictors

AIDS AND BEHAVIOR. 2025; 29(7): 2324-2335 Nº de citas: 1 [doi:10.1007/s10461-025-04695-x]

Bailón, L; Moltó, J; Curran, A; Cadiñanos, J; de Quirós, JCLB; de los Santos, I; Ambrosioni, J; Imaz, A; Benet, S; Suanzes, P; Navarro, J; González-García, J; Busca, C; Pérez-Latorre, L; Berenguer, J; García-Fraile, LJ; Mejia-Abril, G; Miró, JM; Scévola, S; Moreno, S; Domingo, P; Tian, Y; Frankot, M; Lim, D; Cai, YH; Vendrame, E; Guo, S; Wallin, JJ; Geleziunas, R; Sengupta, D; Alarcón-Soto, Y; Leal, I; Aranguen, A; Garcia-Garcia, M; McGowan, I; Brander, C; Arribas, JR; Mothe, B.

Safety, immunogenicity and effect on viral rebound of HTI vaccines combined with a TLR7 agonist in early-treated HIV-1 infection: a randomized, placebo-controlled phase 2a trial

Nature Communications. 2025; 16(1): Nº de citas: 1 [doi:10.1038/s41467-025-57284-w]

Tejerina, F; Peñas-Utrilla, D; Herranz, M; Catalán, P; Marín, M; Mesones, L; García-Domínguez, JM; Merino, B; Pérez, L; Fanciulli, C; Muñoz, P; Rodríguez-Gonzalez, C; Diez, C; Aldámiz, T; Molero-Salinas, A; Pérez-Lago, L; de Viedma, DG.

Chronic Systemic SARS-CoV-2 Infection Without Respiratory Involvement in an Immunocompromised Patient

Viruses-Basel. 2025; 17(2): [doi:10.3390/v17020147]